4
Changes in Ownership
Greenwich LifeSciences, Inc. Filed Acc 0001493152-25-021614
CEO and CFO bought 10,600 shares at $8.43 ($89,358)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Patel Snehal CEO and CFO | 2025-11-07 | Purchase | +10,600 | $8.43 | $89,358 | 5,583,502 | D: show line 1 in the form |
| Open-market purchases · 10,600 sh · avg $8.43 · $89,358 | |||||||
Loading xslF345X05/ownership.xml…